Treatment of hepatitis C virus-related systemic vasculitis
Cacoub, P.; Saadoun, D.; Sene, D.; Limal, N.; Piette, J.-C.
Journal of Rheumatology 32(11): 2078-2082
2005
ISSN/ISBN: 0315-162X PMID: 16265682 Document Number: 585700
Document emailed within 1 workday
Related Documents
Cacoub, P.; Maisonobe, T.; Thibault, V.; Gatel, A.; Servan, J.; Musset, L.; Piette, J.C. 2001: Systemic vasculitis in patients with hepatitis C Journal of Rheumatology 28(1): 109-118Chiba, T.; Matsuzaki, Y.; Abei, M.; Shoda, J.; Tanaka, N.; Osuga, T.; Aikawa, T. 1996: The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma American Journal of Gastroenterology 91(6): 1195-1203
Lamprecht, P.; Moosig, F.; Gause, A.; Herlyn, K.; Gross, W.L. 2000: Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis Clinical and Experimental Rheumatology 18(3): 319-325
Ueda, T.; Chung, H.; Kudo, M. 2011: Effects of interferon treatment on recurrence and survival after curative treatment of hepatitis C virus-related hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 319-324
Castera, L.; Roulot, D.; Trinchet, J.C.; Beaugrand, M. 2001: Hepatitis C virus-related cirrhosis: is antiviral treatment mandatory? Gastroenterologie Clinique et Biologique 25(5): 509-513
Revenga Arranz, F.; Díaz Díaz, R.; Iglesias Díez, L.; Cassis Herce, B.; Sánchez Gómez, F.; Fuertes Ortiz, A. 1995: Cryoglobulinemic vasculitis associated with hepatitis C virus infection. A report of eight cases Acta Dermato-Venereologica 75(3): 234-236
Sollima, S.; Milazzo, L.; Vassalini, P.; Antinori, S.; Galli, M. 2018: Recurrence of mixed cryoglobulinaemia vasculitis following influenza vaccination despite clearance of hepatitis C virus infection Clinical and Experimental Rheumatology 36 Suppl 111(2): 161-162
Généreau, T.; Martin, A.; Lortholary, O.; Nöel, V.; Guillevin, L. 1998: Temporal arteritis symptoms in a patient with hepatitis C virus associated type II cryoglobulinemia and small vessel vasculitis Journal of Rheumatology 25(1): 183-185
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Dmitriev, A.A. 1990: Hemapheresis in treatment of systemic autoimmune vasculitis Progress in Clinical and Biological Research 337: 345-346
Mariette, X. 1998: The hepatitis C virus and systemic diseases Revue du Rhumatisme 65(12): 737-740
Roux, P.; Fugon, L.; Winnock, M.; Salmon-Céron, D.; Lacombe, K.; Sogni, P.; Spire, B.; Dabis, F.ço.; Carrieri, M.P. 2012: Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users Addiction 107(1): 152-159
Galesić, K.; Horvatić, I. 2014: Treatment of anti-neutrophil cytoplasmic antibody related vasculitis Lijecnicki Vjesnik 136(7-8): 232-237
Fedorchenko, S.V.; Tereshchenko, T.M. 1990: The reaferon treatment of a patient with acute viral hepatitis B and hemorrhagic vasculitis Vrachebnoe Delo 10: 104-105
Sakuma, I.; Enomoto, N.; Asahina, Y.; Kurosaki, M.; Sato, C. 1995: Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 930-935
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218